Hlk Biotech Holding Stock Buy Hold or Sell Recommendation
| AMHD Stock | USD 0.0002 0.00 0.00% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding HLK Biotech Holding is 'Strong Sell'. Macroaxis provides HLK Biotech buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AMHD positions.
Check out HLK Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as HLK and provide practical buy, sell, or hold advice based on investors' constraints. HLK Biotech Holding. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
HLK |
Execute HLK Biotech Buy or Sell Advice
The HLK recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on HLK Biotech Holding. Macroaxis does not own or have any residual interests in HLK Biotech Holding or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute HLK Biotech's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
HLK Biotech Trading Alerts and Improvement Suggestions
| HLK Biotech Holding generated a negative expected return over the last 90 days | |
| HLK Biotech Holding has some characteristics of a very speculative penny stock | |
| HLK Biotech Holding has a very high chance of going through financial distress in the upcoming years | |
| HLK Biotech Holding currently holds 600 K in liabilities. HLK Biotech Holding has a current ratio of 0.16, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist HLK Biotech until it has trouble settling it off, either with new capital or with free cash flow. So, HLK Biotech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like HLK Biotech Holding sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for HLK to invest in growth at high rates of return. When we think about HLK Biotech's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 8.33 K. Net Loss for the year was (3.77 K) with loss before overhead, payroll, taxes, and interest of (180 K). | |
| HLK Biotech Holding currently holds about 185.72 K in cash with (1.21 K) of positive cash flow from operations. |
HLK Biotech Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to HLK Biotech or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that HLK Biotech's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a HLK pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
HLK Biotech Volatility Alert
At this time HLK Biotech Holding exhibits very low volatility. HLK Biotech Holding appears to be a penny stock. Although HLK Biotech Holding may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in HLK Biotech Holding or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on HLK instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.HLK Biotech Fundamentals Vs Peers
Comparing HLK Biotech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze HLK Biotech's direct or indirect competition across all of the common fundamentals between HLK Biotech and the related equities. This way, we can detect undervalued stocks with similar characteristics as HLK Biotech or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of HLK Biotech's fundamental indicators could also be used in its relative valuation, which is a method of valuing HLK Biotech by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare HLK Biotech to competition |
| Fundamentals | HLK Biotech | Peer Average |
| Return On Asset | -0.97 | -0.14 |
| Revenue | 8.33 K | 9.43 B |
| Gross Profit | (180 K) | 27.38 B |
| EBITDA | (701.16 K) | 3.9 B |
| Net Income | (3.77 K) | 570.98 M |
| Cash And Equivalents | 185.72 K | 2.7 B |
| Total Debt | 600 K | 5.32 B |
| Current Ratio | 0.16 X | 2.16 X |
| Cash Flow From Operations | (1.21 K) | 971.22 M |
| Number Of Employees | 6 | 18.84 K |
| Beta | 1.99 | -0.15 |
| Market Capitalization | 462.46 K | 19.03 B |
| Total Asset | 116.71 K | 29.47 B |
| Z Score | -19.8 | 8.72 |
| Net Asset | 116.71 K |
HLK Biotech Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as HLK . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 2.0E-4 | |||
| Day Typical Price | 2.0E-4 |
About HLK Biotech Buy or Sell Advice
When is the right time to buy or sell HLK Biotech Holding? Buying financial instruments such as HLK Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having HLK Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Obamacare Thematic Idea Now
Obamacare
Health care services and providers including hospitals, clinics and nursing homes that hope to benefit from Obamacare program. The Obamacare theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Obamacare Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in HLK Pink Sheet
HLK Biotech financial ratios help investors to determine whether HLK Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HLK with respect to the benefits of owning HLK Biotech security.